𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II trial of 2-chlorodeoxyadenosine in patients with relapsed/refractory acute myeloid leukemia: A study of the Eastern Cooperative Oncology Group (ECOG), E5995

✍ Scribed by Michael S Gordon; Molly L Young; Martin S Tallman; Larry D Cripe; John M Bennett; Elisabeth Paietta; Walter Longo; Henry Gerad; Joseph Mazza; Jacob M Rowe

Book ID
114118871
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
70 KB
Volume
24
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

13-cis-retinoic acid in the treatment of
13-cis-retinoic acid in the treatment of elderly patients with acute myeloid leukemia. A phase II pilot study of the eastern cooperative oncology group
✍ Zachary B. Kramer; Laszlo Boros; Peter H. Wiernik; Janet Andersen; John M. Benne πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 297 KB πŸ‘ 2 views

The management of acute myeloid leukemia in the elderly (65 years and older) is unsatisfactory because of poor patient tolerance of standard myeloablative chemotherapy. The authors conducted a Phase II study to evaluate the effectiveness and toxicity of 13-cis-retinoic acid (CRA) in the therapy of e

Phase II trial of gemcitabine in patient
Phase II trial of gemcitabine in patients with advanced sarcomas (E1797) : A trial of the Eastern Cooperative Oncology Group
✍ Scott Okuno; Louise M. Ryan; John H. Edmonson; Dennis A. Priebat; Ronald H. Blum πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 75 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The current study was conducted to evaluate the antitumor activity and toxicity of gemcitabine in patients with advanced sarcoma. ## METHODS Twenty‐five patients with advanced sarcomas, who previously were untreated for metastatic disease, were treated on an Eastern Coo